Learning Objectives
Upon completion of this activity, participants should be able to:
- Recall data from clinical trials highlighting the strengths and weaknesses of the currently approved NNRTIs
- Describe how transmitted NNRTI resistance mutations could influence treatment outcomes
- Discuss the potential clinical benefit of next-generation NNRTIs
CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.